Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5

Publication date: Available online 30 June 2020Source: Acta Pharmaceutica Sinica BAuthor(s): Yang Liu, Xiaojia Liu, Na Zhang, Mingxiao Yin, Jingwen Dong, Qingxuan Zeng, Genxiang Mao, Danqing Song, Lu Liu, Hongbin Deng
Source: Acta Pharmaceutica Sinica B - Category: Cancer & Oncology Source Type: research